aluates Reports

$ 0.0

Automative

Global Long Acting Insulins Market Insights, Forecast to 2030

Published Date: December 2024

Report Code: QYRE-Auto-34I906

Global Long Acting Insulins Market Insights Forecast to 2028

BUY CHAPTERS

Global Long Acting Insulins Market Insights, Forecast to 2030

Code: QYRE-Auto-34I906

Report

December 2024

Pages:76

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Sanofi

Wockhardt UK

Novo Nordisk

Long Acting Insulins Market

Long Acting Insulins (are also called basal or background insulins) can control blood sugar for an entire day. Bovine PZI (protamine zinc insulin), can last anywhere up to 36 hours. Long acting insulins are available in animal and analogue forms. They can be used for a number of different types of diabetes.

Market Analysis and Insights: Global Long Acting Insulins Market

The global Long Acting Insulins market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Long Acting Insulins is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The China market for Long Acting Insulins is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The Europe market for Long Acting Insulins is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The global key companies of Long Acting Insulins include Novo Nordisk, Sanofi and Wockhardt UK, etc. In 2023, the global top five players had a share approximately % in terms of revenue.

Long Acting Insulins is widely used in various fields, such as Home Use, Medical Institutions and Others,, etc. Home Use provides greatest supports to the Long Acting Insulins industry development. In 2023, global % revenue of Long Acting Insulins went into Home Use filed and the proportion will reach to % in 2030.

Report Covers:

This report presents an overview of global market for Long Acting Insulins market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.

This report researches the key producers of Long Acting Insulins, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Long Acting Insulins, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Long Acting Insulins revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Long Acting Insulins market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Long Acting Insulins revenue, projected growth trends, production technology, application and end-user industry.

Market Segmentation

Scope of Long Acting Insulins Market Report

Report Metric	Details
Report Name	Long Acting Insulins Market
Segment by Type	Insulin Glargine Insulin Determir Insulin Degludec Long Acting Animal Insulin
Segment by Application	Home Use Medical Institutions Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Novo Nordisk, Sanofi, Wockhardt UK
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Long Acting Insulins in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Long Acting Insulins companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
Chapter 8: China by Type, and by Application, revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Long Acting Insulins revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions

FAQ for this report

Who are the main players in the Long Acting Insulins Market report?

Ans: The main players in the Long Acting Insulins Market are Novo Nordisk, Sanofi, Wockhardt UK

What are the Application segmentation covered in the Long Acting Insulins Market report?

Ans: The Applications covered in the Long Acting Insulins Market report are Home Use, Medical Institutions, Others

What are the Type segmentation covered in the Long Acting Insulins Market report?

Ans: The Types covered in the Long Acting Insulins Market report are Insulin Glargine, Insulin Determir, Insulin Degludec, Long Acting Animal Insulin

Recommended Reports

Insulin Types & Devices

Diabetes Therapies

Insulin Administration Tools

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Long Acting Insulins Market Size Growth Rate by Type, 2019 VS 2023 VS 2030

1.2.2 Insulin Glargine

1.2.3 Insulin Determir

1.2.4 Insulin Degludec

1.2.5 Long Acting Animal Insulin

1.3 Market by Application

1.3.1 Global Long Acting Insulins Market Size Growth Rate by Application, 2019 VS 2023 VS 2030

1.3.2 Home Use

1.3.3 Medical Institutions

1.3.4 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Long Acting Insulins Market Perspective (2019-2030)

2.2 Global Long Acting Insulins Growth Trends by Region

2.2.1 Long Acting Insulins Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Long Acting Insulins Historic Market Size by Region (2019-2024)

2.2.3 Long Acting Insulins Forecasted Market Size by Region (2025-2030)

2.3 Long Acting Insulins Market Dynamics

2.3.1 Long Acting Insulins Industry Trends

2.3.2 Long Acting Insulins Market Drivers

2.3.3 Long Acting Insulins Market Challenges

2.3.4 Long Acting Insulins Market Restraints

3 Competition Landscape by Key Players

3.1 Global Revenue Long Acting Insulins by Players

3.1.1 Global Long Acting Insulins Revenue by Players (2019-2024)

3.1.2 Global Long Acting Insulins Revenue Market Share by Players (2019-2024)

3.2 Global Long Acting Insulins Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players of Long Acting Insulins, Ranking by Revenue, 2022 VS 2023 VS 2024

3.4 Global Long Acting Insulins Market Concentration Ratio

3.4.1 Global Long Acting Insulins Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Long Acting Insulins Revenue in 2023

3.5 Global Key Players of Long Acting Insulins Head office and Area Served

3.6 Global Key Players of Long Acting Insulins, Product and Application

3.7 Global Key Players of Long Acting Insulins, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Long Acting Insulins Breakdown Data by Type

4.1 Global Long Acting Insulins Historic Market Size by Type (2019-2024)

4.2 Global Long Acting Insulins Forecasted Market Size by Type (2025-2030)

5 Long Acting Insulins Breakdown Data by Application

5.1 Global Long Acting Insulins Historic Market Size by Application (2019-2024)

5.2 Global Long Acting Insulins Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America Long Acting Insulins Market Size (2019-2030)

6.2 North America Long Acting Insulins Market Size by Type

6.2.1 North America Long Acting Insulins Market Size by Type (2019-2024)

6.2.2 North America Long Acting Insulins Market Size by Type (2025-2030)

6.2.3 North America Long Acting Insulins Market Share by Type (2019-2030)

6.3 North America Long Acting Insulins Market Size by Application

6.3.1 North America Long Acting Insulins Market Size by Application (2019-2024)

6.3.2 North America Long Acting Insulins Market Size by Application (2025-2030)

6.3.3 North America Long Acting Insulins Market Share by Application (2019-2030)

6.4 North America Long Acting Insulins Market Size by Country

6.4.1 North America Long Acting Insulins Market Size by Country: 2019 VS 2023 VS 2030

6.4.2 North America Long Acting Insulins Market Size by Country (2019-2024)

6.4.3 North America Long Acting Insulins Market Size by Country (2025-2030)

6.4.4 U.S.

6.4.5 Canada

7 Europe

7.1 Europe Long Acting Insulins Market Size (2019-2030)

7.2 Europe Long Acting Insulins Market Size by Type

7.2.1 Europe Long Acting Insulins Market Size by Type (2019-2024)

7.2.2 Europe Long Acting Insulins Market Size by Type (2025-2030)

7.2.3 Europe Long Acting Insulins Market Share by Type (2019-2030)

7.3 Europe Long Acting Insulins Market Size by Application

7.3.1 Europe Long Acting Insulins Market Size by Application (2019-2024)

7.3.2 Europe Long Acting Insulins Market Size by Application (2025-2030)

7.3.3 Europe Long Acting Insulins Market Share by Application (2019-2030)

7.4 Europe Long Acting Insulins Market Size by Country

7.4.1 Europe Long Acting Insulins Market Size by Country: 2019 VS 2023 VS 2030

7.4.2 Europe Long Acting Insulins Market Size by Country (2019-2024)

7.4.3 Europe Long Acting Insulins Market Size by Country (2025-2030)

7.4.3 Germany

7.4.4 France

7.4.5 U.K.

7.4.6 Italy

7.4.7 Russia

7.4.8 Nordic Countries

8 China

8.1 China Long Acting Insulins Market Size (2019-2030)

8.2 China Long Acting Insulins Market Size by Type

8.2.1 China Long Acting Insulins Market Size by Type (2019-2024)

8.2.2 China Long Acting Insulins Market Size by Type (2025-2030)

8.2.3 China Long Acting Insulins Market Share by Type (2019-2030)

8.3 China Long Acting Insulins Market Size by Application

8.3.1 China Long Acting Insulins Market Size by Application (2019-2024)

8.3.2 China Long Acting Insulins Market Size by Application (2025-2030)

8.3.3 China Long Acting Insulins Market Share by Application (2019-2030)

9 Asia (excluding China)

9.1 Asia Long Acting Insulins Market Size (2019-2030)

9.2 Asia Long Acting Insulins Market Size by Type

9.2.1 Asia Long Acting Insulins Market Size by Type (2019-2024)

9.2.2 Asia Long Acting Insulins Market Size by Type (2025-2030)

9.2.3 Asia Long Acting Insulins Market Share by Type (2019-2030)

9.3 Asia Long Acting Insulins Market Size by Application

9.3.1 Asia Long Acting Insulins Market Size by Application (2019-2024)

9.3.2 Asia Long Acting Insulins Market Size by Application (2025-2030)

9.3.3 Asia Long Acting Insulins Market Share by Application (2019-2030)

9.4 Asia Long Acting Insulins Market Size by Region

9.4.1 Asia Long Acting Insulins Market Size by Region: 2019 VS 2023 VS 2030

9.4.2 Asia Long Acting Insulins Market Size by Region (2019-2024)

9.4.3 Asia Long Acting Insulins Market Size by Region (2025-2030)

9.4.4 Japan

9.4.5 South Korea

9.4.6 China Taiwan

9.4.7 Southeast Asia

9.4.8 India

9.4.9 Australia

10 Middle East, Africa, and Latin America

10.1 Middle East, Africa, and Latin America Long Acting Insulins Market Size (2019-2030)

10.2 Middle East, Africa, and Latin America Long Acting Insulins Market Size by Type

10.2.1 Middle East, Africa, and Latin America Long Acting Insulins Market Size by Type (2019-2024)

10.2.2 Middle East, Africa, and Latin America Long Acting Insulins Market Size by Type (2025-2030)

10.2.3 Middle East, Africa, and Latin America Long Acting Insulins Market Share by Type (2019-2030)

10.3 Middle East, Africa, and Latin America Long Acting Insulins Market Size by Application

10.3.1 Middle East, Africa, and Latin America Long Acting Insulins Market Size by Application (2019-2024)

10.3.2 Middle East, Africa, and Latin America Long Acting Insulins Market Size by Application (2025-2030)

10.3.3 Middle East, Africa, and Latin America Long Acting Insulins Market Share by Application (2019-2030)

10.4 Middle East, Africa, and Latin America Long Acting Insulins Market Size by Country

10.4.1 Middle East, Africa, and Latin America Long Acting Insulins Market Size by Country: 2019 VS 2023 VS 2030

10.4.2 Middle East, Africa, and Latin America Long Acting Insulins Market Size by Country (2019-2024)

10.4.3 Middle East, Africa, and Latin America Long Acting Insulins Market Size by Country (2025-2030)

10.4.4 Brazil

10.4.5 Mexico

10.4.6 Turkey

10.4.7 Saudi Arabia

10.4.8 Israel

10.4.9 GCC Countries

11 Key Players Profiles

11.1 Novo Nordisk

11.1.1 Novo Nordisk Company Details

11.1.2 Novo Nordisk Business Overview

11.1.3 Novo Nordisk Long Acting Insulins Introduction

11.1.4 Novo Nordisk Revenue in Long Acting Insulins Business (2019-2024)

11.1.5 Novo Nordisk Recent Developments

11.2 Sanofi

11.2.1 Sanofi Company Details

11.2.2 Sanofi Business Overview

11.2.3 Sanofi Long Acting Insulins Introduction

11.2.4 Sanofi Revenue in Long Acting Insulins Business (2019-2024)

11.2.5 Sanofi Recent Developments

11.3 Wockhardt UK

11.3.1 Wockhardt UK Company Details

11.3.2 Wockhardt UK Business Overview

11.3.3 Wockhardt UK Long Acting Insulins Introduction

11.3.4 Wockhardt UK Revenue in Long Acting Insulins Business (2019-2024)

11.3.5 Wockhardt UK Recent Developments

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

FEATURED COMPANIES

Sanofi

Wockhardt UK

Novo Nordisk

List of Tables

Table 1. Global Long Acting Insulins Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030

Table 2. Key Players of Insulin Glargine

Table 3. Key Players of Insulin Determir

Table 4. Key Players of Insulin Degludec

Table 5. Key Players of Long Acting Animal Insulin

Table 6. Global Long Acting Insulins Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030

Table 7. Global Long Acting Insulins Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030

Table 8. Global Long Acting Insulins Market Size by Region (2019-2024) & (US$ Million)

Table 9. Global Long Acting Insulins Market Share by Region (2019-2024)

Table 10. Global Long Acting Insulins Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 11. Global Long Acting Insulins Market Share by Region (2025-2030)

Table 12. Long Acting Insulins Market Trends

Table 13. Long Acting Insulins Market Drivers

Table 14. Long Acting Insulins Market Challenges

Table 15. Long Acting Insulins Market Restraints

Table 16. Global Long Acting Insulins Revenue by Players (2019-2024) & (US$ Million)

Table 17. Global Long Acting Insulins Revenue Share by Players (2019-2024)

Table 18. Global Top Long Acting Insulins by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Long Acting Insulins as of 2023)

Table 19. Global Long Acting Insulins Industry Ranking 2022 VS 2023 VS 2024

Table 20. Global 5 Largest Players Market Share by Long Acting Insulins Revenue (CR5 and HHI) & (2019-2024)

Table 21. Global Key Players of Long Acting Insulins, Headquarters and Area Served

Table 22. Global Key Players of Long Acting Insulins, Product and Application

Table 23. Global Key Players of Long Acting Insulins, Product and Application

Table 24. Mergers & Acquisitions, Expansion Plans

Table 25. Global Long Acting Insulins Market Size by Type (2019-2024) & (US$ Million)

Table 26. Global Long Acting Insulins Revenue Market Share by Type (2019-2024)

Table 27. Global Long Acting Insulins Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 28. Global Long Acting Insulins Revenue Market Share by Type (2025-2030)

Table 29. Global Long Acting Insulins Market Size by Application (2019-2024) & (US$ Million)

Table 30. Global Long Acting Insulins Revenue Share by Application (2019-2024)

Table 31. Global Long Acting Insulins Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 32. Global Long Acting Insulins Revenue Share by Application (2025-2030)

Table 33. North America Long Acting Insulins Market Size by Type (2019-2024) & (US$ Million)

Table 34. North America Long Acting Insulins Market Size by Type (2025-2030) & (US$ Million)

Table 35. North America Long Acting Insulins Market Size by Application (2019-2024) & (US$ Million)

Table 36. North America Long Acting Insulins Market Size by Application (2025-2030) & (US$ Million)

Table 37. North America Long Acting Insulins Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 38. North America Long Acting Insulins Market Size by Country (2019-2024) & (US$ Million)

Table 39. North America Long Acting Insulins Market Size by Country (2025-2030) & (US$ Million)

Table 40. Europe Long Acting Insulins Market Size by Type (2019-2024) & (US$ Million)

Table 41. Europe Long Acting Insulins Market Size by Type (2025-2030) & (US$ Million)

Table 42. Europe Long Acting Insulins Market Size by Application (2019-2024) & (US$ Million)

Table 43. Europe Long Acting Insulins Market Size by Application (2025-2030) & (US$ Million)

Table 44. Europe Long Acting Insulins Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 45. Europe Long Acting Insulins Market Size by Country (2019-2024) & (US$ Million)

Table 46. Europe Long Acting Insulins Market Size by Country (2025-2030) & (US$ Million)

Table 47. China Long Acting Insulins Market Size by Type (2019-2024) & (US$ Million)

Table 48. China Long Acting Insulins Market Size by Type (2025-2030) & (US$ Million)

Table 49. China Long Acting Insulins Market Size by Application (2019-2024) & (US$ Million)

Table 50. China Long Acting Insulins Market Size by Application (2025-2030) & (US$ Million)

Table 51. Asia Long Acting Insulins Market Size by Type (2019-2024) & (US$ Million)

Table 52. Asia Long Acting Insulins Market Size by Type (2025-2030) & (US$ Million)

Table 53. Asia Long Acting Insulins Market Size by Application (2019-2024) & (US$ Million)

Table 54. Asia Long Acting Insulins Market Size by Application (2025-2030) & (US$ Million)

Table 55. Asia Long Acting Insulins Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030

Table 56. Asia Long Acting Insulins Market Size by Region (2019-2024) & (US$ Million)

Table 57. Asia Long Acting Insulins Market Size by Region (2025-2030) & (US$ Million)

Table 58. Middle East, Africa, and Latin America Long Acting Insulins Market Size by Type (2019-2024) & (US$ Million)

Table 59. Middle East, Africa, and Latin America Long Acting Insulins Market Size by Type (2025-2030) & (US$ Million)

Table 60. Middle East, Africa, and Latin America Long Acting Insulins Market Size by Application (2019-2024) & (US$ Million)

Table 61. Middle East, Africa, and Latin America Long Acting Insulins Market Size by Application (2025-2030) & (US$ Million)

Table 62. Middle East, Africa, and Latin America Long Acting Insulins Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 63. Middle East, Africa, and Latin America Long Acting Insulins Market Size by Country (2019-2024) & (US$ Million)

Table 64. Middle East, Africa, and Latin America Long Acting Insulins Market Size by Country (2025-2030) & (US$ Million)

Table 65. Novo Nordisk Company Details

Table 66. Novo Nordisk Business Overview

Table 67. Novo Nordisk Long Acting Insulins Product

Table 68. Novo Nordisk Revenue in Long Acting Insulins Business (2019-2024) & (US$ Million)

Table 69. Novo Nordisk Recent Developments

Table 70. Sanofi Company Details

Table 71. Sanofi Business Overview

Table 72. Sanofi Long Acting Insulins Product

Table 73. Sanofi Revenue in Long Acting Insulins Business (2019-2024) & (US$ Million)

Table 74. Sanofi Recent Developments

Table 75. Wockhardt UK Company Details

Table 76. Wockhardt UK Business Overview

Table 77. Wockhardt UK Long Acting Insulins Product

Table 78. Wockhardt UK Revenue in Long Acting Insulins Business (2019-2024) & (US$ Million)

Table 79. Wockhardt UK Recent Developments

Table 80. Research Programs/Design for This Report

Table 81. Key Data Information from Secondary Sources

Table 82. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Long Acting Insulins Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)

Figure 2. Global Long Acting Insulins Market Share by Type: 2023 VS 2030

Figure 3. Insulin Glargine Features

Figure 4. Insulin Determir Features

Figure 5. Insulin Degludec Features

Figure 6. Long Acting Animal Insulin Features

Figure 7. Global Long Acting Insulins Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)

Figure 8. Global Long Acting Insulins Market Share by Application: 2023 VS 2030

Figure 9. Home Use Case Studies

Figure 10. Medical Institutions Case Studies

Figure 11. Others Case Studies

Figure 12. Long Acting Insulins Report Years Considered

Figure 13. Global Long Acting Insulins Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 14. Global Long Acting Insulins Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 15. Global Long Acting Insulins Market Share by Region: 2023 VS 2030

Figure 16. Global Long Acting Insulins Market Share by Players in 2023

Figure 17. Global Top Long Acting Insulins Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Long Acting Insulins as of 2023)

Figure 18. The Top 10 and 5 Players Market Share by Long Acting Insulins Revenue in 2023

Figure 19. North America Long Acting Insulins Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 20. North America Long Acting Insulins Market Share by Type (2019-2030)

Figure 21. North America Long Acting Insulins Market Share by Application (2019-2030)

Figure 22. North America Long Acting Insulins Market Share by Country (2019-2030)

Figure 23. United States Long Acting Insulins Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 24. Canada Long Acting Insulins Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 25. Europe Long Acting Insulins Market Size YoY (2019-2030) & (US$ Million)

Figure 26. Europe Long Acting Insulins Market Share by Type (2019-2030)

Figure 27. Europe Long Acting Insulins Market Share by Application (2019-2030)

Figure 28. Europe Long Acting Insulins Market Share by Country (2019-2030)

Figure 29. Germany Long Acting Insulins Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 30. France Long Acting Insulins Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 31. U.K. Long Acting Insulins Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 32. Italy Long Acting Insulins Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 33. Russia Long Acting Insulins Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 34. Nordic Countries Long Acting Insulins Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 35. China Long Acting Insulins Market Size YoY (2019-2030) & (US$ Million)

Figure 36. China Long Acting Insulins Market Share by Type (2019-2030)

Figure 37. China Long Acting Insulins Market Share by Application (2019-2030)

Figure 38. Asia Long Acting Insulins Market Size YoY (2019-2030) & (US$ Million)

Figure 39. Asia Long Acting Insulins Market Share by Type (2019-2030)

Figure 40. Asia Long Acting Insulins Market Share by Application (2019-2030)

Figure 41. Asia Long Acting Insulins Market Share by Region (2019-2030)

Figure 42. Japan Long Acting Insulins Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 43. South Korea Long Acting Insulins Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 44. China Taiwan Long Acting Insulins Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 45. Southeast Asia Long Acting Insulins Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 46. India Long Acting Insulins Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 47. Australia Long Acting Insulins Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 48. Middle East, Africa, and Latin America Long Acting Insulins Market Size YoY (2019-2030) & (US$ Million)

Figure 49. Middle East, Africa, and Latin America Long Acting Insulins Market Share by Type (2019-2030)

Figure 50. Middle East, Africa, and Latin America Long Acting Insulins Market Share by Application (2019-2030)

Figure 51. Middle East, Africa, and Latin America Long Acting Insulins Market Share by Country (2019-2030)

Figure 52. Brazil Long Acting Insulins Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 53. Mexico Long Acting Insulins Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 54. Turkey Long Acting Insulins Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 55. Saudi Arabia Long Acting Insulins Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 56. Israel Long Acting Insulins Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 57. GCC Countries Long Acting Insulins Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 58. Novo Nordisk Revenue Growth Rate in Long Acting Insulins Business (2019-2024)

Figure 59. Sanofi Revenue Growth Rate in Long Acting Insulins Business (2019-2024)

Figure 60. Wockhardt UK Revenue Growth Rate in Long Acting Insulins Business (2019-2024)

Figure 61. Bottom-up and Top-down Approaches for This Report

Figure 62. Data Triangulation

Figure 63. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$4900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Protamine Zinc Insulin Market Research Report 2024

Global Protamine Zinc Insulin Injection Market Research Report 2024

Global Low Protamine Zinc Insulin Market Research Report 2024

Global Long Acting Insulin Analogue Market Research Report 2025

Global Short acting Insulin Market Research Report 2024

Global Premixed Insulin Analogs Market Research Report 2024

Global Insulin Glargine and Lispro Market Research Report 2024

Global Ultra Long Acting Insulin Market Research Report 2025

Global Insulin Storage Devices Market Research Report 2024

Global Insulin Drugs for Diabetes Market Research Report 2024

Global Insulin Coolers Market Research Report 2024

Global Insulin Raw Material Market Research Report 2025

Global Premixed Human Insulin Market Research Report 2024

Global Insulin Glargine Sales Market Report Competitive Analysis and Regional Opportunities 2025 2031

Global Rapid Acting Insulins Market Insights Forecast to 2030

Global Insulin Preparation Market Research Report 2025

Global Animal Insulin Market Insights Forecast to 2030

Global Insulin API Market Insights Forecast to 2030

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions